Advancing Product Quality: a Summary of the Inaugural FDA/PQRI Conference
Journal Title: The AAPS Journal - Year 2015, Vol 17, Issue 4
Abstract
On September 16 and 17, 2014, the Food and Drug Administration (FDA) and Product Quality Research Institute (PQRI) inaugurated their Conference on Evolving Product Quality. The Conference is conceived as an annual forum in which scientists from regulatory agencies, industry, and academia may exchange viewpoints and work together to advance pharmaceutical quality. This Conference Summary Report highlights key topics of this conference, including (1) risk-based approaches to pharmaceutical development, manufacturing, regulatory assessment, and post-approval changes; (2) FDA-proposed quality metrics for products, facilities, and quality management systems; (3) performance-based quality assessment and clinically relevant specifications; (4) recent developments and implementation of continuous manufacturing processes, question-based review, and European Medicines Agency (EMA)-FDA pilot for Quality-by-Design (QbD) applications; and (5) breakthrough therapies, biosimilars, and international harmonization, focusing on ICH M7 and Q3D guidelines. The second FDA/PQRI conference on advancing product quality is planned for October 5–7, 2015.
Authors and Affiliations
Lawrence X. Yu, Jeffrey Baker, Susan C. Berlam, Ashley Boam, E. J. Brandreth, Lucinda Buhse, Thomas Cosgrove, David Doleski, Lynne Ensor, Joseph Famulare, Mohan Ganapathy, Gustavo Grampp, David Hussong, Robert Iser, Gordon Johnston, Filippos Kesisoglou, Mansoor Khan, Steven Kozlowski, Emanuela Lacana, Sau L. Lee, Stephen Miller, Sarah Pope Miksinski, Christine M. V. Moore, Theresa Mullin, G. K. Raju, Andre Raw, Susan Rosencrance, Mark Rosolowsky, Paul Stinavage, Hayden Thomas, Russell Wesdyk, Joerg Windisch, Sivakumar Vaithiyalingam
Keywords
Related Articles
- EP ID EP680983
- DOI 10.1208/s12248-015-9754-4
- Views 37
- Downloads 0
Tiered Approaches to Chromatographic Bioanalytical Method Performance Evaluation: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Team
The A2 harmonization team, a part of the Global Bioanalysis Consortium (GBC), focused on defining possible tiers of chromatographic-based bioanalytical method performance. The need for developing bioanalytical methods su...
Penetratin-Mediated Transepithelial Insulin Permeation: Importance of Cationic Residues and pH for Complexation and Permeation
The online version of this article (doi:10.1208/s12248-015-9747-3) contains supplementary material, which is available to authorized users.
Electronic and resonance effects on the lonization of structural analogues of efavirenz
The solubility of 4 analogues of efavirenz was studied as a function of pH. The study evaluated the ionization behavior and determined the relative contribution of electronegative substituents versus resonance effects on...
Characterization of the distribution, polymorphism, and stability of nimodipine in its solid dispersions in polyethylene glycol by micro-Raman spectroscopy and powder x-ray diffraction
In the present study, a series of solid dispersions of the drug nimodipine using polyethylene glycol as carrier were prepared following the hot-melt method. Micro-Raman spectroscopy in conjunction with X-ray powder diffr...
Method Transfer, Partial Validation, and Cross Validation: Recommendations for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Team
This paper presents the recommendations of the Global Bioanalytical Consortium Harmonization Team on method transfer, partial validation, and cross validation. These aspects of bioanalytical method validation, while impo...